VEGFA and age-related macular degeneration: Similarly, Schworm et al. reported CT and SRF reductions with extended anti-VEGF treatment, suggesting that pachychoroid neovasculopathy patients might require more intensive therapy compared to AMD patients to achieve optimal choroidal effects [13].